PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Synaptic dysfunction driven by toxic amyloid Aβ oligomers (Aβo) is one of the early events in Alzheimer’s disease (AD) leading to cognitive decline, disability, and death. We have shown that optoacoustic therapy/NPLT can be used for traumatic brain injury (TBI) treatment. We have also shown that mature neurons generated from the NPLT-treated rat hippocampal neural stem cells (NSCs) had significantly lower Aβo levels. Here we used a custom-made 808-nm optoacoustic system to study autophagy pathways changes induced by NPLT. Our results suggest that autophagy pathways are upregulated in NPLT-treated NSCs compared to sham which could lead to enhanced Aβo clearance.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Kevin J. Johnson, Auston C. Grant, Kathia M. Johnson, Rinat O. Esenaliev, Giulio Taglialatela, Maria-Adelaide Micci, "Nano-pulsed laser therapy (NPLT) for clearance of AD-related toxic oligomers," Proc. SPIE PC12842, Photons Plus Ultrasound: Imaging and Sensing 2024, PC1284225 (13 March 2024); https://doi.org/10.1117/12.3008996